About TICAGRELOR IP/BP/EP/USP
Ticagrelor is a medication used to prevent blood clots in people with heart-related conditions. It works by blocking receptors on platelets, which are cells in the blood involved in clotting. By preventing these receptors from being activated, ticagrelor helps reduce the risk of heart attacks, strokes, and other serious heart problems. It is taken as a tablet by mouth and is usually prescribed alongside other medications for heart health.
High-Quality Pharmaceutical Raw MaterialTicagrelor IP/BP/EP/USP is recognized for its superior purity (>=99%) and regulatory compliance, making it a reliable choice for pharmaceutical manufacturers. With robust impurity control and precise specifications, it serves as the active pharmaceutical ingredient (API) in tablet formulations for acute coronary syndrome.
Versatile Packaging for Varied NeedsThe product is conveniently supplied in double LDPE bags housed within HDPE drums, available in 1kg, 5kg, and 10kg sizes. This ensures optimal protection from moisture and contaminants during storage and transport, maintaining product integrity through its full shelf life.
Application in Therapeutic Tablet FormulationsUsed in pharmaceutical tablet manufacturing, Ticagrelor functions as a potent antiplatelet agent. Its scientifically recognized molecular structure and proven efficacy make it essential for the treatment of patients with acute coronary syndrome, improving therapeutic outcomes.
FAQ's of TICAGRELOR IP/BP/EP/USP:
Q: How should Ticagrelor IP/BP/EP/USP be stored to maintain its quality?
A: Ticagrelor should be stored below 25C, with the container kept tightly closed and protected from light. Its packaging in double LDPE bags within HDPE drums helps preserve stability and avoid exposure to moisture, contaminants, and sunlight.
Q: What is the main usage of Ticagrelor as a pharmaceutical raw material?
A: Ticagrelor is primarily used as an antiplatelet agent in the form of an API for tablet formulations. It is indicated for the treatment and management of acute coronary syndrome to reduce the risk of cardiovascular events.
Q: When is Ticagrelor IP/BP/EP/USP applied in pharmaceutical manufacturing?
A: Ticagrelor is utilized during the process of preparing tablet dosage forms, particularly when formulating medications intended for patients with acute coronary syndrome and requiring antiplatelet therapy.
Q: Where is Ticagrelor IP/BP/EP/USP manufactured and supplied from?
A: This pharmaceutical raw material is manufactured, supplied, and traded in India, ensuring compliance with international standards such as IP/BP/EP/USP.
Q: What are the benefits of using Ticagrelor with >=99% purity in tablet formulation?
A: Using Ticagrelor with high purity ensures consistent therapeutic efficacy, safety, and regulatory compliance in the final tablet product. It helps avoid variability in clinical outcomes and meets stringent pharmaceutical requirements.
Q: How is the solubility of Ticagrelor relevant to its application?
A: Ticagrelor's slight solubility in water and high solubility in ethanol and methanol facilitate its use in various formulation processes, making it adaptable to different manufacturing requirements for efficient tablet production.